Omega-7 (Sea Buckthorn) — Frequently Asked Questions

Omega-3 (EPA/DHA) is a polyunsaturated fatty acid that primarily works through anti-inflammatory pathways and membrane fluidity. Omega-7 (palmitoleic acid) is a monounsaturated fatty acid that functions as a lipokine — a signaling molecule between fat tissue and the liver. They have complementary but distinct mechanisms: omega-3 excels at reducing triglycerides and inflammation, while omega-7 uniquely influences hepatic lipogenesis and insulin signaling. They can be safely taken together.

The evidence is promising but still emerging. There is one well-designed RCT (Bernstein et al., 2014) showing impressive triglyceride and CRP reductions, plus strong mechanistic data from animal studies. However, we lack large-scale human trials with cardiovascular endpoints. Omega-7 is reasonable to try for people seeking additional cardiometabolic support beyond omega-3, especially if they have elevated CRP or triglycerides, but it should not replace proven interventions like omega-3, statins, or lifestyle changes.